• Enayat, M.S., Guilliatt, A.M., Lester, W., Wilde, J.T., Williams, M.D. & Hill, F.G.H. (2006) Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance. British Journal of Haematology, 133, 664666.
  • Favaloro, E.J. (2006a) 2B or not 2B? Differential identification of Type 2B, versus pseudo-, von Willebrand disease. British Journal of Haematology, 135, 141142.
  • Favaloro, E.J. (2006b) Laboratory identification of von Willebrand disease: technical and scientific perspectives. Seminars in Thrombosis and Hemostasis, 32, 456471.
  • Matsubara, Y., Murata, M., Sugita, K. & Ikeda, Y. (2003) Identification of a novel point mutation in platelet glycoprotein I α, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease. Journal of Thrombosis and Haemostasis, 1, 21982205.
  • Nurden, P., Lanza, F., Bonnafous-Faurie, C. & Nurden, A. (2007) A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GP1BA gene. Thrombosis and Haemostasis, 97, 319321.
  • Othman, M., Notley, C., Lavender, F.L., White, H., Byrne, C.D., Lillicrap, D. & O’Shaughnessy, D.F. (2005) Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GP1BA gene resulting in platelet-type von Willebrand disease. Blood, 105, 43304336.
  • Whalley, I.N. & Perry, D.J. (2006) 2B or not 2B? Differential identification of type 2B, versus pseudo-,von Willebrand disease. British Journal of Haematology, 136, 345.